Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LAP3 | P28838 | 5/20 | 0.50 |
| ▸ | ANPEP | P15144 | 6/20 | 0.44 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | METAP1 | P53582 | 2/20 | 0.39 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.38 |
| ▸ | FDPS | P14324 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aminomethylenebisphosphonic Acid SCHEMBL11300742 | 0.90 | KDM4E (0.48) | LAP3ANPEPERAP1ALDH1A1TDP1 | |
| Methylamine SCHEMBL11796432 | 0.84 | LAP3 (0.50) | LAP3ANPEPERAP1ALDH1A1TDP1 | |
| Aminomethylenebisphosphonic Acid SCHEMBL11420468 | 0.84 | LAP3 (0.50) | LAP3ANPEPERAP1ALDH1A1TDP1 | |
| SCHEMBL230835 | 0.84 | LAP3 (0.47) | LAP3ANPEPERAP1ALDH1A1TDP1 | |
| Aminomethylenebisphosphonic Acid SCHEMBL402218 | 0.84 | ANPEP (0.47) | LAP3ANPEPERAP1ALDH1A1TDP1 | |
| SCHEMBL9539964 | 0.81 | LAP3 (0.45) | LAP3ANPEPERAP1ALDH1A1TDP1 | |
| SCHEMBL27852339 | 0.81 | LAP3 (0.45) | LAP3ANPEPERAP1ALDH1A1TDP1 | |
| SCHEMBL27857546 | 0.81 | LAP3 (0.45) | LAP3ANPEPERAP1ALDH1A1TDP1 | |
| SCHEMBL22346009 | 0.81 | LAP3 (0.45) | LAP3ANPEPERAP1ALDH1A1TDP1 | |
| Methyl Alcohol SCHEMBL11367531 | 0.81 | LAP3 (0.45) | LAP3ANPEPERAP1ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3023520-B1 | ENVIRONMENTALLY FRIENDLY GOLD ELECTROPLATING COMPOSITIONS AND CORRESPONDING METHOD | ROHM & HAAS ELECT MAT (US) | 2019-01-30 | — | — | EP | disclosed |
| US-20160145756-A1 | ENVIRONMENTALLY FRIENDLY GOLD ELECTROPLATING COMPOSITIONS AND METHODS | ROHM AND HAAS ELECRONIC MATERIALS LLC | 2016-05-26 | — | — | US | disclosed |
| EP-3023520-A1 | ENVIRONMENTALLY FRIENDLY GOLD ELECTROPLATING COMPOSITIONS AND METHODS | Rohm and Haas Electronic Materials LLC (US) | 2016-05-25 | — | — | EP | disclosed |
| EP-2109439-B1 | OPHTHALMIC COMPOSITIONS WITH A DISUCCINATE | BAUSCH & LOMB (US) | 2011-04-13 | — | — | EP | disclosed |
| US-7897553-B2 | Ophthalmic compositions comprising polymeric biguanide compositions; used as an antimicrobial component in an ophthalmic lens care solution, or as preservative in pharmaceutical composition or other health care product; good efficacy and lower toxicity | BAUSCH & LOMB INCORPORATED (US) | 2011-03-01 | — | — | US | disclosed |
| US-7670997-B2 | Ophthalmic compositions comprising a branched, glycerol monoalkyl compound and a fatty acid monoester | BAUSCH & LOMB INCORPORATED (US) | 2010-03-02 | — | — | US | disclosed |
| EP-2109439-A1 | OPHTHALMIC COMPOSITIONS WITH A DISUCCINATE | Bausch & Lomb Incorporated (US) | 2009-10-21 | — | — | EP | disclosed |
| EP-2073800-A2 | OPHTHALMIC COMPOSITIONS COMPRISING DIGLYCINE | Bausch & Lomb Incorporated (US) | 2009-07-01 | — | — | EP | disclosed |
| WO-2009048860-A1 | OPHTHALMIC COMPOSITIONS WITH A DISUCCINATE | BAUSCH & LOMB INCORPORATED (US) | 2009-04-16 | — | — | WO | disclosed |
| US-20090092575-A1 | OPHTHALMIC COMPOSITIONS WITH A DISUCCINATE | BAUSCH & LOMB INCORPORATED | 2009-04-09 | — | — | US | disclosed |
| US-20080095754-A1 | OPHTHALMIC COMPOSITIONS COMPRISING DIGLYCINE | BAUSCH & LOMB INCORPORATED | 2008-04-24 | — | — | US | disclosed |
| WO-2007146683-A2 | OPHTHALMIC COMPOSITIONS COMPRISING A BRANCHED, GLYCEROL MONOALKYL COMPOUND AND A FATTY ACID MONOESTER | BAUSCH & LOMB INCORPORATED (US) | 2007-12-21 | — | — | WO | disclosed |
| WO-2007146684-A1 | OPHTHALMIC COMPOSITIONS COMPRISING A BRANCHED, GLYCEROL COMPOUND AND A CATIONIC ANTIMICROBIAL | BAUSCH & LOMB INCORPORATED (US) | 2007-12-21 | — | — | WO | disclosed |
| US-20070286767-A1 | Ophthalmic Compositions Comprising a Branched, Glycerol Monoalkyl Compound and a Fatty Acid Monoester | BAUSCH & LOMB PHARMA HOLDINGS CORP. | 2007-12-13 | — | — | US | disclosed |
| US-20070287752-A1 | Ophthalmic Compositions Comprising A Branched, Glycerol Compound | BAUSCH & LOMB INCORPORATED | 2007-12-13 | — | — | US | disclosed |
| EP-0883407-B1 | TREATMENT OF CONTACT LENSES WITH AQUEOUS SOLUTION INCLUDING PHOSPHONIC COMPOUNDS | BAUSCH & LOMB (US) | 2002-04-24 | — | — | EP | disclosed |
| US-5858937-A | EFFICIENT REMOVAL OF PROTEIN DEPOSITS | BAUSCH & LOMB INCORPORATED (US) | 1999-01-12 | — | — | US | disclosed |
| EP-0883407-A1 | TREATMENT OF CONTACT LENSES WITH AQUEOUS SOLUTION INCLUDING PHOSPHONIC COMPOUNDS | BAUSCH & LOMB INCORPORATED (US) | 1998-12-16 | — | — | EP | disclosed |
| WO-1997031659-A1 | TREATMENT OF CONTACT LENSES WITH AQUEOUS SOLUTION INCLUDING PHOSPHONIC COMPOUNDS | BAUSCH & LOMB INCORPORATED (US) | 1997-09-04 | — | — | WO | disclosed |
| US-4013586-A | Vanadium catalysts prepared with phosphonates | MONSANTO COMPANY (US) | 1977-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070287752-A1 | Ophthalmic Compositions Comprising A Branched, Glycerol Compound | GK, MGLL, BAK1 | LAP3 3720/4885ANPEP 2710/4885ERAP1 4327/4885 |
| US-20080095754-A1 | OPHTHALMIC COMPOSITIONS COMPRISING DIGLYCINE | MAN1B1, TREH, FUT6 | LAP3 1126/4885ANPEP 453/4885ERAP1 181/4885 |
| US-20090092575-A1 | OPHTHALMIC COMPOSITIONS WITH A DISUCCINATE | ASS1, DEGS1, ODC1 | LAP3 4649/4885ANPEP 4435/4885ERAP1 4633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.